SEC 13F Intelligence

Weaver C. Barksdale & Associates, Inc. / GILD

Weaver C. Barksdale & Associates, Inc.’s Gilead Sciences Inc Position

Does Weaver C. Barksdale & Associates, Inc. own Gilead Sciences Inc (GILD)? Yes — 17.0K shares worth $2M (+2.26% of its 13F portfolio) as of Q1 2026, down from 17.8K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
17.0K
% of Portfolio
+2.26%
Quarters Held
15
currently held

Position History GILD

Reported value by quarter
Q3 ’22: $2MQ3 ’22Q4 ’22: $3MQ1 ’23: $2MQ1 ’23Q2 ’23: $2MQ3 ’23: $2MQ3 ’23Q4 ’23: $2MQ1 ’24: $2MQ1 ’24Q2 ’24: $2MQ3 ’24: $2MQ3 ’24Q4 ’24: $2MQ1 ’25: $2MQ1 ’25Q2 ’25: $2MQ3 ’25: $2MQ3 ’25Q4 ’25: $2MQ1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202617.0K$2M+2.26%
Q4 202517.8K$2M+2.29%
Q3 202519.8K$2M+2.12%
Q2 202521.1K$2M+2.24%
Q1 202521.1K$2M+2.27%
Q4 202423.7K$2M+2.09%
Q3 202424.3K$2M+1.83%
Q2 202425.2K$2M+1.64%
Q1 202425.5K$2M+1.72%
Q4 202325.7K$2M+2.04%
Q3 202332.5K$2M+2.08%
Q2 202327.3K$2M+2.08%
Q1 202329.0K$2M+2.25%
Q4 202230.1K$3M+2.28%
Q3 202229.3K$2M+1.81%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Weaver C. Barksdale & Associates, Inc.’s full portfolio or all institutional holders of GILD.